Iconovo AB

Summary

Iconovo AB (Iconovo) is a medical device company that develops, manufactures, and supplies in inhalation devices. The company offers devices, formulation, analytical testing, documentation, and others. Its products include ICOres, a reservoir-based dry powder inhaler; ICOone is a unit-dose disposable dry powder inhaler; ICOcap, a capsule-based dry powder inhaler; ICOpre is a per-metered dry powder inhaler which carries formulations. The company's products are widely used in the treatment of asthma and respiratory disorders. Iconovo is headquartered in Lund, Sweden

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Iconovo AB
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


Iconovo AB Company Overview
Iconovo AB Company Snapshot
Iconovo AB Pipeline Products and Ongoing Clinical Trials Overview
Iconovo AB – Pipeline Analysis Overview
Iconovo AB - Key Facts
Iconovo AB - Major Products and Services
Iconovo AB Pipeline Products by Development Stage
Iconovo AB Pipeline Products Overview
ICOpre
ICOpre Product Overview
ICOres
ICOres Product Overview
Multi-Dose Delivery Device
Multi-Dose Delivery Device Product Overview
Iconovo AB - Key Competitors
Iconovo AB - Key Employees
Iconovo AB - Locations And Subsidiaries
Head Office
Recent Developments
Iconovo AB, Recent Developments
Jan 10, 2020: Orest Lastow change role to CTO and Johan Waborg hired as new CEO of iconovo
Nov 19, 2019: Iconovo has been granted ICOres patent in Japan
Jul 10, 2019: Positive results from clinical study with ICOres
May 22, 2019: Iconovo welcomes Dr. Agneta Walhagen as new member of the Board of Directors at Iconovo.
Feb 15, 2019: Iconovo is hiring an Analytical Chemist to strengthen the full development cycle of medicinal inhalers and inhalation formulations
Feb 05, 2019: Roger Lassing joins Iconovo as VP business development
Jan 25, 2019: The European Patent Organization, EPO, has announced its intention to approve a patent for Iconovo’s inhaler platform, ICOres.
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Iconovo AB Pipeline Products and Ongoing Clinical Trials Overview
Iconovo AB Pipeline Products by Equipment Type
Iconovo AB Pipeline Products by Indication
Iconovo AB, Key Facts
Iconovo AB, Major Products and Services
Iconovo AB Number of Pipeline Products by Development Stage
Iconovo AB Pipeline Products Summary by Development Stage
ICOpre - Product Status
ICOpre - Product Description
ICOres - Product Status
ICOres - Product Description
Multi-Dose Delivery Device - Product Status
Multi-Dose Delivery Device - Product Description
Iconovo AB, Key Employees
Glossary
List of Figures
Iconovo AB Pipeline Products by Equipment Type
Iconovo AB Pipeline Products by Development Stage

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook